Drug profile · INN
dapagliflozin || metformin
DAPAGLIFLOZIN AND METFORMIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dapagliflozin || metformin (DAPAGLIFLOZIN AND METFORMIN) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
INN dapagliflozin || metformin
Brand DAPAGLIFLOZIN AND METFORMIN
Formulation TABLET
Frequently asked questions
What is dapagliflozin || metformin?
dapagliflozin || metformin (DAPAGLIFLOZIN AND METFORMIN) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for dapagliflozin || metformin?
DAPAGLIFLOZIN AND METFORMIN is a marketed brand name for dapagliflozin || metformin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dapagliflozin || metformin?
dapagliflozin || metformin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.